Related references
Note: Only part of the references are listed.Myeloma bone disease: from biology findings to treatment approaches
Evangelos Terpos et al.
BLOOD (2019)
The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3
Xinling Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Monoclonal gammopathy of undetermined significance
Tarek H. Mouhieddine et al.
BLOOD (2019)
Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells
Ameet K. Mishra et al.
LEUKEMIA (2019)
Osteoclasts secrete osteopontin into resorption lacunae during bone resorption
Jani Luukkonen et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2019)
Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes
Tore Bjerregaard Stage et al.
BONE (2018)
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Yi Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
Yan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
Michael H. Tomasson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Impact of metformin on the progression of MGUS to multiple myeloma
Ben Boursi et al.
LEUKEMIA & LYMPHOMA (2017)
Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice
Sheila Bornstein et al.
ENDOCRINOLOGY (2017)
Diabetes, bone and glucose-lowering agents: basic biology
Beata Lecka-Czernik
DIABETOLOGIA (2017)
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
Navdeep S. Chandel et al.
CELL METABOLISM (2016)
Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells
Nicole M. A. White-Al Habeeb et al.
PROSTATE (2016)
Bone metastasis: the importance of the neighbourhood
Peter I. Croucher et al.
NATURE REVIEWS CANCER (2016)
Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
Fu-Ming Zi et al.
CANCER LETTERS (2015)
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib
S. Jagannathan et al.
LEUKEMIA (2015)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study
Su-Hsin Chang et al.
LANCET HAEMATOLOGY (2015)
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
Sevim Dalva-Aydemir et al.
CLINICAL CANCER RESEARCH (2015)
Osteoblastic niche supports the growth of quiescent multiple myeloma cells
Zheng Chen et al.
BLOOD (2014)
The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma
W. Wu et al.
BRITISH JOURNAL OF CANCER (2014)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity
Jessal J. Patel et al.
CELL BIOCHEMISTRY AND FUNCTION (2014)
Effects of Rosiglitazone vs Metformin on Circulating Osteoclast and Osteogenic Precursor Cells in Postmenopausal Women with Type 2 Diabetes Mellitus
M. R. Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton et al.
ELIFE (2014)
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy
Benjamin Boyerinas et al.
BLOOD (2013)
Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
Bindiya Thakkar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
J. Jeyabalan et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line AN IN VITRO STUDY
M. Salai et al.
BONE & JOINT JOURNAL (2013)
Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2
Won Gu Jang et al.
BONE (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass
M. Shah et al.
BONE (2010)
Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats
Ying Gao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Metformin reverses the deleterious effects of high glucose on osteoblast function
Donghu Zhen et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Osteoblast Differentiation Is Functionally Associated With Decreased AMP Kinase Activity
Takayuki Kasai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression
Ippei Kanazawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma
Yazan Alsayed et al.
BLOOD (2007)
Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
AM Cortizo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Monoclonal gammopathy of undetermined significance
Robert A. Kyle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma
G Carlinfante et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Share Paper
